Alyeska Investment Group’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
Other funds holding ETNB
RCM
PCM
DTC
SCM
ACA
GCL
Alyeska Investment Group's ETNB Position: Q3 2025 in Review
Alyeska Investment Group sold out of 89bio (ETNB) in Q3 2025, closing a stake of 576,973 shares — an estimated $5.67M sold.
Alyeska Investment Group first reported a position in ETNB in Q4 2019 and held it in 17 quarters. The position peaked at $7.24M in Q4 2024. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.
- Alyeska Investment Group reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
- Alyeska Investment Group sold 576,973 89bio shares in Q3 2025, an estimated $5.67M.
- Alyeska Investment Group first reported a position in 89bio in Q4 2019 and held it in 17 quarters.
- Alyeska Investment Group's 89bio position peaked at $7.24M in Q4 2024.
- 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.
Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.